Novo Nordisk stock slumped 21.83% to fall to a new three-year low. It was the stock’s worst daily loss since a 26.15% fall on Oct. 19, 1987. It’s fallen 24.77% over the past two days, its ...

Then, suddenly, its fortunes took a turn. Novo Nordisk’s share price has plummeted more than 50 percent this year, pushing it out of the top ten list of Europe’s most valuable companies.

Shares in Novo Nordisk NOVO.B 0.16% plunged after it cut its guidance, a result from the company losing its lead in the booming market for weight-loss drugs, opening the door to competitors such ...

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its full-year sales and profit outlook for the second time this year. The ...

Novo Nordisk slashed its financial forecasts as it struggled to fight off competition in the United States. It also named a new chief executive, who highlighted the “urgency” of the moment.

U.S.-listed shares of Novo Nordisk (NVO) rose 0.5% in early premarket trading Wednesday after the Danish drugmaker reported second-quarter sales of its blockbuster weight-loss drug Wegovy soared ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.

Shares in Wegovy maker Novo Nordisk fell further on Wednesday as analysts warned of persistent competition from copycat drugs in the United States, a day after a profit warning and the naming of a ...

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a profit warning and named a new CEO, as it battles rising competition in ...

Novo Nordisk, which makes blockbuster weight-loss drugs Ozempic and Wegovy, now expects 2025 sales growth at constant exchange rates of 8% to 14%, down from its early May forecast of 13% to 21%.

Shares of Novo Nordisk had their worst single day since the Black Monday crash of 1987 after a profit warning and the announcement its new CEO will be an insider. Novo Nordisk stock NVO +2.38% NOVO.B ...